Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Small study hopes to personalize anesthesia for liver transplant patients

NCT ID NCT06909942

Knowledge-focused Sponsor: Inonu University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 3 liver transplant patients to see if muscle loss (sarcopenia) changes how the body responds to the muscle relaxant rocuronium. Researchers measured hand grip strength and used a questionnaire to diagnose sarcopenia before surgery, then tracked how long the drug lasted. The goal was to find if lower doses could be used safely, potentially reducing time spent in the hospital and on a ventilator.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

3 people

The number who actually took part.

Started

Apr 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with American Society of Anesthesiologists (ASA) 3-4, * Patients over the age of 18, * Liver transplant recipient candidates who have agreed to receive an organ transplant Exclusion Criteria: * Patients who are unconscious enough to not be included in the study (patients for whom consent cannot be obtained and the study cannot be explained) * Patients under the age of 18 * Patients aged 65 and over * Patients with advanced renal failure * Patients with massive ascites in the abdomen * Patients with advanced heart failure or high pulmonary artery pressure for whom routine anesthesia induction protocols must be excluded * Patients with psychosis or substance abuse Patients with a known adverse reaction to rocuronium * Patients who received massive blood and blood product transfusions during surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver transplantation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver transplantation Sarcopenia Sarcopenia in liver cirrhosis

Contacts and locations

Locations

  • Turgut Ozal Medicine Center Liver Transplantation Institute

    Malatya, Battalgazi, 44040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.